N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide

C24H22N4O5 — CID 95089874

IUPACN-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide
SMILESC[C@@H]1Cc2ccccc2N1C(=O)c1ccc(=O)n(CC(=O)Nc2ccc3c(c2)OCCO3)n1
InChIInChI=1S/C24H22N4O5/c1-15-12-16-4-2-3-5-19(16)28(15)24(31)18-7-9-23(30)27(26-18)14-22(29)25-17-6-8-20-21(13-17)33-11-10-32-20/h2-9,13,15H,10-12,14H2,1H3,(H,25,29)/t15-/m1/s1
InChIKeyDLAFCRQOFYJYCX-OAHLLOKOSA-N
MW446.46 g/mol
LogP2.24
Rot. Bonds4

About N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide (PubChem CID 95089874) has the molecular formula C24H22N4O5 and a molecular weight of 446.46 g/mol. Its IUPAC name is N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide.

Molecular Properties

Compound NameN-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide
PubChem CID95089874
Molecular FormulaC24H22N4O5
Molecular Weight446.46 g/mol
Exact Mass446.16
IUPAC NameN-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide
SMILESC[C@@H]1Cc2ccccc2N1C(=O)c1ccc(=O)n(CC(=O)Nc2ccc3c(c2)OCCO3)n1
InChIInChI=1S/C24H22N4O5/c1-15-12-16-4-2-3-5-19(16)28(15)24(31)18-7-9-23(30)27(26-18)14-22(29)25-17-6-8-20-21(13-17)33-11-10-32-20/h2-9,13,15H,10-12,14H2,1H3,(H,25,29)/t15-/m1/s1
InChIKeyDLAFCRQOFYJYCX-OAHLLOKOSA-N
XLogP2.24
TPSA102.76 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500446.46
LogP ≤ 52.24
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide?
The IUPAC name of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide (CID 95089874) is N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide.
What is the SMILES notation for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide?
The canonical SMILES for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide is C[C@@H]1Cc2ccccc2N1C(=O)c1ccc(=O)n(CC(=O)Nc2ccc3c(c2)OCCO3)n1.
What is the InChIKey of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide?
The InChIKey is DLAFCRQOFYJYCX-OAHLLOKOSA-N. The full InChI is InChI=1S/C24H22N4O5/c1-15-12-16-4-2-3-5-19(16)28(15)24(31)18-7-9-23(30)27(26-18)14-22(29)25-17-6-8-20-21(13-17)33-11-10-32-20/h2-9,13,15H,10-12,14H2,1H3,(H,25,29)/t15-/m1/s1.
What are the key properties of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide?
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide has a molecular weight of 446.46 g/mol, XLogP of 2.24, 4 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-[(2R)-2-methyl-2,3-dihydroindole-1-carbonyl]-6-oxopyridazin-1-yl]acetamide is sourced from PubChem (CID 95089874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).